Becca Henry completed her BSc at the University of Sydney in 2010 and was awarded first class honours in Microbiology. Her thesis work involved wet lab research of Mycobacterium ethene monooxygenase.
She gained experience in clinical trial coordinating in Neurology pharmacology trials and joined the Kirby Institute in 2017, where she joined TVRP and was a coordinator for the START clinical trial. She commenced her PhD in 2018 and is studying Tuberculosis and HIV co-infection in resource-limited countries. Her work focuses on the inflammatory and immunologic effects of HIV-associated TB.